MediPharm Labs Corp. (TSX:LABS)
0.0750
+0.0050 (7.14%)
Jun 12, 2026, 3:33 PM EST
MediPharm Labs Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9.87 | 10.81 | 11.69 | 17.98 | 24.15 | 34.11 |
Cash & Short-Term Investments | 9.87 | 10.81 | 11.69 | 17.98 | 24.15 | 34.11 |
Cash Growth | 16.85% | -7.56% | -34.99% | -25.53% | -29.21% | 71.30% |
Accounts Receivable | 6.53 | 7.53 | 7.51 | 5.87 | 12.88 | 16.92 |
Inventory | 8.47 | 8.02 | 8.71 | 9.9 | 7.78 | 10.98 |
Other Current Assets | 0.86 | 1.11 | 5.17 | 2.89 | 2.55 | 3.54 |
Total Current Assets | 25.73 | 27.47 | 33.08 | 36.63 | 93.86 | 65.55 |
Net Property, Plant & Equipment | 17.26 | 17.6 | 19.16 | 25.27 | 18.11 | 25.89 |
Other Intangible Assets | 0.63 | 0.68 | 0.85 | 1.03 | 0.04 | 0.04 |
Other Long-Term Assets | - | - | 0.64 | 1 | - | 0.88 |
Total Assets | 43.62 | 45.74 | 53.73 | 63.94 | 65.5 | 92.36 |
Accounts Payable | 7.68 | 9.2 | 7.86 | 6.75 | 7.12 | 6.21 |
Accrued Expenses | 0.82 | 0.52 | 2.3 | 1.89 | 1.74 | 2.55 |
Short-Term Debt | 0.02 | 0.2 | 0.34 | 2.23 | 0.6 | 0.11 |
Unearned Revenue | - | - | - | - | - | 0 |
Total Current Liabilities | 8.52 | 9.93 | 10.5 | 10.86 | 9.46 | 8.88 |
Long-Term Debt | - | - | 0.05 | 0.07 | 0.03 | 0.1 |
Other Long-Term Liabilities | - | - | - | - | - | 0.24 |
Total Long-Term Liabilities | - | - | 0.05 | 0.07 | 0.03 | 0.34 |
Total Liabilities | 8.52 | 9.93 | 10.55 | 10.93 | 9.49 | 9.22 |
Common Stock | 201.9 | 201.9 | 201.21 | 200.24 | 191.26 | 190.55 |
Additional Paid-in Capital | 3.55 | 3.4 | 29.56 | 29.53 | 28.4 | 21.91 |
Accumulated Other Comprehensive Income | -0.11 | -0.11 | -0.16 | -0.04 | - | 0.03 |
Retained Earnings | -170.25 | -169.38 | -187.43 | -176.73 | -163.65 | -129.34 |
Shareholders' Equity | 35.1 | 35.81 | 43.18 | 53.01 | 56.01 | 83.15 |
Total Liabilities & Equity | 43.62 | 45.74 | 53.73 | 63.94 | 65.5 | 92.36 |
Total Debt | 0.02 | 0.2 | 0.39 | 2.3 | 0.63 | 0.22 |
Net Cash (Debt) | 9.85 | 10.61 | 11.3 | 15.69 | 23.51 | 33.89 |
Net Cash Growth | -7.14% | -6.17% | -27.95% | -33.29% | -30.63% | 2834.55% |
Net Cash Per Share | 0.02 | 0.03 | 0.03 | 0.04 | 0.09 | 0.14 |
Book Value | 35.1 | 35.81 | 43.18 | 53.01 | 56.01 | 83.15 |
Book Value Per Share | 0.08 | 0.09 | 0.11 | 0.15 | 0.20 | 0.33 |
Tangible Book Value | 34.47 | 35.14 | 42.33 | 51.97 | 55.97 | 83.1 |
Tangible Book Value Per Share | 0.08 | 0.08 | 0.10 | 0.14 | 0.20 | 0.33 |